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Abstract
The molecular mechanism of entry of herpesviruses requires a multicomponent fusion system. Cell invasion by Herpes
simplex virus (HSV) requires four virally encoded glycoproteins: namely gD, gB and gH/gL. The role of gB has remained
elusive until recently when the crystal structure of HSV-1 gB became available and the fusion potential of gB was clearly
demonstrated. Although much information on gB structure/function relationship has been gathered in recent years, the
elucidation of the nature of the fine interactions between gB fusion loops and the membrane bilayer may help to
understand the precise molecular mechanism behind herpesvirus-host cell membrane fusion. Here, we report the first
biophysical study on the two fusion peptides of gB, with a particular focus on the effects determined by both peptides on
lipid bilayers of various compositions. The two fusion loops constitute a structural subdomain wherein key hydrophobic
amino acids form a ridge that is supported on both sides by charged residues. When used together the two fusion loops
have the ability to significantly destabilize the target membrane bilayer, notwithstanding their low bilayer penetration when
used separately. These data support the model of gB fusion loops insertion into cholesterol enriched membranes.
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Introduction
Enveloped viruses infect host cells by fusion of viral and target
membranes. The initial apposition step is followed by fusion of the
outer leaflets of membranes (the hemifusion step), leading to the
formation of a transient fusion intermediate, which evolves into
the fusion of inner leaflets and the formation of a pore, with the
mixing of the internal compartments of both fusion partners.
Thus, the viral genome is transferred to the cytoplasm of the host
cell and viral replication ensues [1–3]. This fusion event is
triggered by specific glycoproteins in the viral envelope. Fusion
glycoproteins belong to either class I, class II or the newly
described class III, depending upon their arrangement at the
surface of the virion, their structure and the location within the
protein of a short stretch of hydrophobic amino acids called the
fusion peptide, which is able to induce the initial lipid
destabilization that ends in fusion [4].
Although, viral fusion proteins are divided in three classes and
the cellular membrane undergoing fusion might vary (plasma
membrane vs. endosomal membrane), these proteins have to act
on lipid assemblies. Thus, lipids contribute to fusion through their
physical, mechanical and/or chemical properties and play a role
in determining the preferential partitioning of some amino acid
sequences into membrane microdomains called ‘‘rafts’’, and/or in
modulating the curvature of the membranes involved in the fusion
process [3].
Considering lipids and fusion proteins the necessary partners
involved in the fusion process, it becomes clear that the overall gist
of viral-induced membrane fusion is dictated by several features
common to different families of viruses [1]. All fusion machineries
need to interact with lipids, so they possess hydrophobic segments
(fusion peptides) or are able after rearrangements to make
hydrophobic interactions with membranes; moreover, need to
adopt specific conformations related to the pre and post-fusion
states, since fusion is limited in space and time. Therefore,
different viruses infect their host cells by very similar mechanisms
at the molecular level and fusion peptides represent a key element
of the fusion machinery, being the trigger for controlled
membrane destabilization.
Recently, the novel concept of ‘‘lipid packing sensor’’ emerged,
indicating protein motifs or domains that recognize the curvature
of lipid membranes. The most studied sensor is the amphipathic
helical motif present both in cellular membrane proteins and in
viral proteins [5,6]; but also other structural motifs, such as loops
or unfolded peptides, may be involved in the sensing of the
membrane curvature and in the initial steps of membrane fusion.
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e32186The discovery of sensor motifs opens new perspectives with respect
to viral fusion proteins, which may contain such sensors; and may
help our understanding of the subtle and complex interplay
between protein-induced fusion and lipid modulation and may
represent targets for future antiviral therapies.
Herpes simplex virus type 1 (HSV-1) is a member of the a-
herpesvirus subfamily and enters cells through fusion of the viral
envelope with a cellular membrane in a cascade of molecular
interactions involving multiple viral glycoproteins and cellular
receptors. The envelope glycoproteins gH/gL, gB and gD are all
essential for the entry process [7] and expression of this quartet of
glycoproteins induces the fusion of cellular membranes in the
absence of virus infection [8]. gH/gL and gB, also play important
roles in primary fusion events that occur during egress of the
capsid from the nucleus of infected cells [9]. Recently, it was
shown that gB and gH/gL interact with each other concomitantly
with fusion and that this interaction is triggered by binding of gD
to its cellular receptor [10,11]. Thus, gB may function coopera-
tively with gH/gL, and each may have some fusogenic potential
on its own. Although gB and gH/gL constitute the core fusion
machinery of all members of the Herpesviridae, their mechanisms
of action are still under investigation.
Peptides derived from the ectodomain of gH block virus entry
[12], while others have the ability to bind and disrupt model
membranes [13–18]. The recently solved crystal structure of the
gH-gL complex [19] showed that gH has no structural homology
with any known fusion protein supporting the hypothesis that gH
may act as a regulator of fusion through interactions with gB,
while the crystal structure of the gH-gL complex of EBV presents
considerable differences in the structural arrangements of domains
supporting the view that the complex can undergo dynamic
rearrangements [7,20].
gB is highly conserved within all the members of the
Herpesviridae and is involved in virus attachment, penetration
and cell-to-cell spread. gB may undergo large conformational
changes to bring about fusion and even though evidence for its
refolding has yet to be obtained a model for pre-fusion gB has been
proposed and it seems that gB undergoes a refolding transition
during fusion. The structures of gB from HSV-1 [21] and EBV
[22] demonstrated that gB has structural homology with viral
fusion proteins belonging to other virus families: the vesicular
stomatitis virus (VSV) G protein [23] and the baculovirus protein
gp64 [24] and is probably the key fusion protein; moreover,
several synthetic gB peptides induced the fusion of large
unilamellar vesicles and inhibited herpes virus infection [25,26].
gB belongs to a newly formed group of fusion proteins, class III,
which share similar individual domain structures and contain a
central three-stranded coiled-coil reminiscent of the class I
proteins. Whereas class I proteins have an N-terminal fusion
peptide, class III proteins have internal bipartite fusion loops
within domain I which are similar to the single fusion loop of class
II fusion proteins. The class II fusion loop is composed entirely of
hydrophobic amino acids whereas those of gB have both
hydrophobic and charged residues [21–24]. In particular, the
fusogenic loops correspond to the domains 173–179 and 258–265
of the protein gB.
Hydrophobic amino acids within the gB loops (W174, F175,
G176, Y179, A261) are essential for gB function [27]. Similar
studies of VSV G, gp64 and EBV gB support the notion that
hydrophobic amino acids of both fusion loops are critical for fusion
[28,29] and together constitute a fusion domain. Moreover, also
charged amino acids play a fundamental role, in fact, mutations of
H263 or R264 also negatively affected gB function [27]. These
data support the view that the two fusion loops constitute a
subdomain where key hydrophobic amino acids form a ridge that
is flanked on both sides by charged amino acids that enhance the
ability to interact with target membranes, in fact, one of the two
gB fusion loops (namely HB168–186) was identified by highly
interfacial hydrophobicity analysis without the aid of structural
data [25].
Although much information has been gathered in recent years,
we do not yet know the precise molecular mechanism behind
herpesvirus host cell membrane fusion; thus, elucidating the nature
of the fine interactions between gB fusion loops and the membrane
may help to districate this interesting matter. In the present study,
we report the synthesis and characterization of membrane
interactions of the two fusion peptides present in gB. The goals
of the experiments reported here were to verify the fusion ability of
the two peptides, to assess the dependence of the fusion activity on
the composition of the membrane and in particular on the content
of cholesterol and to verify the eventual presence of a synergic or
cooperative effect when the two isolated peptides are used
together.
As far as we know, this is the first biophysical study on the two
putative fusion peptides of gB, with a particular focus on the effects
determined by both peptides on lipid bilayers of various
compositions.
Results
Design of peptides
The proposed post-fusion structure of gB ectodomain is
comprised of three protomers, and each protomer coils around
the others with a left-handed twist [21]. There are multiple
contacts between protomers throughout the molecule contributing
to trimer stability. Each protomer of gB can be divided into five
distinct domains: I, base; II, middle, III, core; IV crown; and V,
arm (Figure 1). Domain I (Ile154 to Val363) is a b sandwich
composed of two nearly orthogonal b sheets of four and three
strands, with a long loop and short helix covering one opening of
the b sandwich. An insertion (Tyr165 to Ile272) between strands
b4 and b11 creates a subdomain at the base of the trimer,
consisting of a four-stranded b sheet (with three long and one short
strand), the convex side of which is covered with an a helix, a b
hairpin, and a short two-stranded b sheet; the four-stranded b-
sheet presents hydrophobic tips that have been proposed to
represent the fusion peptides of gB (Figure 1). Fusion peptides are
generally considered as being domains with a high interfacial
hydrophobicity calculated with the Wimley-White hydrophobicity
scale which was systematically used for searching fusion peptides in
other viral glycoproteins. HB168–186, comprising the precise
fusion loop HB173–179 [21], is located in the insertion between
strands b4 and b11 and we were able to identify this region on the
basis of its hydrophobicity, and analyse its role in peptide/lipid
fusion assays [25]. The second loop (HB258–265), identified on
the basis of structural data [21] contributes to the formation of the
bipartite fusion peptide, but does not correspond to a hydropho-
bicity peak calculated with the interfacial scale and thus was not
considered in our previous study [25].
Both fusion loops have been characterized by point-mutations
in the protein sequence and showed to be critical for gB function
in cell fusion [30]. In the present study, we report on the structural
characterization of the two fusion loops by using peptides
corresponding to their sequences. We synthesised a short version,
corresponding exactly to the sequences of the loops, and a longer
version, embracing the flanking b-sheets, in order to understand
the contributions of each region that constitutes the gB fusogenic
domain (Table 1). Moreover, we tried to understand the
Herpes Virus gB Fusion Peptides
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membrane and fusogenic peptides.
Ability of peptides to induce lipid mixing
To investigate the fusogenicity of gB peptides, NBD and Rho
labelled PE were used as the donor and acceptor of fluorescence
energy transfer. A population of LUVs labelled with both was
mixed with a population of unlabelled LUVs and increasing
amounts of peptides were added. Dilution of the fluorescent-
labelled vesicles via membrane fusion induced by the peptide
results in a reduction of the fluorescence energy transfer efficiency,
hence dequenching of the donor fluorescence. The dependence of
the extent of lipid mixing on the peptide to lipid molar ratio was
analysed. The fusogenic capacity was monitored by measuring
their ability to induce lipid mixing of model membranes composed
of DOPG, DOPG/Chol (3/2), DOPC, DOPC/Chol (3/2),
POPC/Chol (3/2), and POPC/Chol/SM at various ratios (4/1/1,
2/1/1, 1/1/1).
Interestingly, there was a different behaviour of the peptides
depending on the lipid composition of LUVs. Figure 2A and B
show the results of lipid mixing assays in LUVs of different
compositions for peptides HB168–186 and HB254–270. The
graphs show that in all tested conditions HB168–186 has higher
fusogenic ability. DOPC/Chol, POPC/Chol and DOPG/Chol all
proved to be good fusogenic conditions. Furthermore, it is evident
from the results obtained that DOPG in presence or absence of
cholesterol represents a less fusogenic condition, indicating that the
negatively charged phospholipids are not preferred. This is a
rather interesting result as both peptides contain arginine residues
and thus we could expect a greater interaction with anionic lipids.
Several viruses such as HIV, influenza virus and Semliki Forest
virus have been shown to involve lipid microdomains, which are
enriched in cholesterol during virus budding as well as virus entry.
Also herpesvirus has been shown to require cholesterol [31,32],
and such a need for cholesterol has also been highlighted in our
experiments using model membranes where a significant increase
in fusion is always observed in presence of cholesterol. The lipids
allowing the highest level of fusion are DOPC and POPC which
are both zwitterionic but present a difference in their unsaturation,
with POPC having only one unsaturated acyl chain and DOPC
having two. DOPC results in a more flexible bilayer, which
appears to be an important feature for the fusion activity of the
analyzed peptides. We also tested the peptide fusion ability of
liposomes containing sphingomyelin, a component commonly
found in lipid rafts. The ternary lipid system POPC/Chol/SM is a
good model for lipid rafts and from the ternary phase diagram [33]
it is possible to determine the boundaries for lipid rafts which are
strongly dependent on the percentage of each lipid in the system.
We used three different conditions to probe the activity of our
peptides in LUVs mimicking rafts: POPC/Chol/SM 4/1/1, 2/1/1
and 1/1/1, characterized by different percentages of the liquid
Figure 1. Three dimensional structure of a single gB protomer. The different domains are shown. In the insert are shown molecular details of
the two fusion loops: HB168–186 (green) and HB254–270 (red).
doi:10.1371/journal.pone.0032186.g001
Table 1. Peptides.
Sequence
HB168–186 NH2-VTVSQVWFGHRYSQFMGIF-COOH
HB173–179 NH2-VWFGHRY-COOH
HB254–270 NH2-YNPSRVEAFHRYGTTVN-COOH
HB258–265 NH2-RVEAFHRY-COOH
scrambled NH2-MRWFSVVSYQVIGTQFGFH-COOH
doi:10.1371/journal.pone.0032186.t001
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(Figure 2 C–D) show that both peptides present a significant
percentage of fusion
Figure 2E shows the results obtained in DOPC/Chol for the
peptides HB168–186 and HB254–270 as well as their shorter
versions corresponding exactly to the loop sequences derived from
Figure 2. Ability of peptides to induce lipid mixing. Peptide-promoted membrane fusion as determined by lipid mixing; peptide aliquots were
added to 0.1 mM LUVs, containing 0.6% NBD and 0.6% Rho. The increase in fluorescence was measured after the addition of peptide aliquots;
reduced Triton-X-100 (0.05% v/v) was referred to as 100% of fusion. In figure is reported the dose dependence of lipid mixing at 37uC: panels A and B
HB168–186 and HB254–270 in LUVs of different composition; panels C and D HB168–186 and HB254–270 in LUVs mimicking lipid rafts; panel E
HB168–186, HB254–270 and shorter versions in DOPC/Chol LUVs; panel F equimolecular mixtures of peptides HB168–186 and HB254–270 in DOPC/
Chol (3/2) and POPC/Chol/SM (2/1/1).
doi:10.1371/journal.pone.0032186.g002
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179 and HB258–265) induced lower levels of fusion compared to
longer sequences, suggesting that shorter peptides were unable to
cross or stably position inside the bilayer. This result further
supports the view that fusion loops are structured by the overall
organization of the fusion domain of the protein and longer
peptides are, therefore, necessary to evidence an appreciable
fusion activity.
In the case of the peptide equimolar mixtures (Figure 2F), we
can observe that in DOPC/Chol as well as in POPC/Chol/SM
(2/1/1) we have a significant fusion activity supporting a
cooperative mechanism.
Ability of peptides to induce lipid mixing of inner-
monolayer
In the inner monolayer assay, the fluorescence from the vesicle
membranes’ outer monolayer is eliminated by the addition of an
aqueous reducing agent, and this experiment reveals the extent of
lipid mixing between the inner monolayers of vesicles in solution.
Figure 3A shows a significant fusion of the inner monolayer in
DOPC/Chol. This is slightly lower than the fusion level obtained
in the lipid mixing experiment, since the latter measures both
hemi-fusion and complete fusion. Therefore, this assay clearly
indicates that the two peptides are able to induce fusion of both the
inner and the outer monolayers.
We also verified the ability of peptide equimolar mixtures to
induce lipid mixing of the inner-monolayer. The results obtained
indicate that the peptides cooperate in the fusion process.
Ability of peptides to induce membrane leakage
In order to explore the effects of the peptides in the
destabilization of membrane vesicles, we studied their effect on
the release of encapsulated fluorophores in model membranes
made of DOPC/Chol. A content-mixing assay (Figure 3B) was
employed to monitor any mixing of internal vesicle components as
a result of vesicle exposure to HB168–186 and HB254–270.
Release of ANTS and DPX from vesicle is commonly used as a
measure of bilayer perturbation and interpreted as ‘‘transient pore
formation’’ [34,35]. Content-mixing is manifested by a decrease in
fluorescence intensity if vesicles encapsulating fluorescent cargo
(e.g., ANTS) merge contents with those containing quenchers (e.g.,
DPX). The leakage experiment shows that the probe did not leak
out significantly to the medium after the interaction with any of
the peptides used in this study. Figure 3B shows that no content-
mixing occurs over the same P/L range where substantial outer
and inner monolayer lipid-mixing occurs, confirming that vesicle
fusion may happen within our system without concomitant pore
formation. The low leakage value observed for both peptides
might be due to the fact that they are located at the membrane
interface and do not completely traverse the bilayer. We also
verified the eventual ability of equimolar mixtures of HB168–186
and HB254–270 to induce membrane leakage, but no significant
difference from results obtained for individual peptides was
detected.
Peptide aggregation
The peptide’s aggregation state in buffer and DOPC/Chol
LUVs was assayed using ThT [36], in order to know the possible
effects of the peptide aggregation on the membranes. As observed
in Figure 4 A–B, the two peptides present a completely different
behaviour. The peptide HB168–186 at a concentration of 4 mM
(Figure 4A) is already aggregated in an aqueous medium, in fact,
the fluorescence change increased dramatically after the addition
of the peptide from a stock solution, while in the presence of
DOPC/Chol a lower aggregation is reported. The peptide
HB254–270 is not aggregated in the aqueous medium nor in the
presence of DOPC/Chol at the same concentration. Furthermore,
we studied the intrinsic relationship between the concentration of
the peptides and the aggregation in buffer and in LUVs and we
can interpret the data for HB168–186 reported in Figure 4C as
aggregated both in the aqueous medium and in LUVs at high
concentrations. Our results are consistent with two hypothesis; the
first is an initial aggregation in the aqueous medium, followed by a
disaggregation when initially interacting with the membrane and
again an aggregation inside the membrane bilayer, indicating that
the insertion of the peptide into the membrane could occur in a
monomeric form and only afterwards the peptide aggregates
again; while the second hypothesis is that the peptide can interact
with the membranes already in an oligomerized state.
Tryptophan/tyrosine fluorescence emission analysis
We measured the intrinsic fluorescence of HB168–186 and
HB254–270 (due to the presence of a tryptophan residue in the
sequence of HB168–186 and two tyrosines for HB254–270) to
evaluate the degree of penetration of the peptides into the
membrane bilayer. We compared the fluorescence emission
spectra in DOPC/Chol vesicles with that in buffer (data not
shown). The quantum yield of aromatic residues of a peptide or
protein normally changes when the amino acid is located in a
more hydrophobic environment such as a phospholipid mem-
brane, normally increasing the intensity of the fluorescence
emission and shifting the maximal spectral position toward shorter
wavelengths (blue shift). Changes in the spectral properties were
observed for both peptides, suggesting that the single tryptophan
residue of HB168–186 and the two tyrosines of HB254–270 move
to a less polar environment upon interaction with lipids. Emission
intensity was enhanced and the maxima shifted to lower
wavelength. (Figure S1) Blue shifts of this magnitude are generally
observed when amphiphilic aromatic-containing peptides interact
with phospholipid bilayers and are consistent with the aromatic
moiety becoming partially immersed in the membrane, further
suggesting that the analysed peptides are capable of penetrating a
lipid bilayer [37].
The increase in fluorescence for tryptophan or tyrosines binding
to membrane phospholipids was used for the generation of binding
isotherms for HB168–186 and HB254–270, therefore partition
coefficients could be calculated. The concentrations of peptides
used were low enough to cause minimal aggregation in the
aqueous phase and were assumed not to disrupt the bilayer
structure. To determine the surface partition coefficient, the
fluorescence intensities were converted to moles of bound peptide
per moles of lipid and plotted as a function of the free peptide
concentration as described in material and methods (Figure 5). As
partition coefficients depend on the concentration of lipid
accessible to peptide, the curves obtained by plotting Xb* (the
molar ratio of bound peptide per 60% of the total lipid) vs Cf (the
equilibrium concentration of free peptide in the solution) are
referred to as the conventional binding isotherms. The shape of a
binding isotherm of a peptide can provide information on the
organization of the peptide within the membrane. A straight line
indicates a simple adhesion process. The shape of the binding
isotherm of all the peptides tested was not linear indicating that
peptide accumulation at the surface is not a simple phenomenon
without cooperative association. In particular, this behaviour is the
hallmark for peptides that self-associate at membrane surfaces
upon partitioning. If aggregation occurred only in the water but
not in the bilayer phase, the opposite course of the isotherms
Herpes Virus gB Fusion Peptides
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pronounced flattening; thus, the shape of the isotherms obtained
could be interpreted as reflecting a process whereby peptides first
incorporate into the membrane and then aggregate there within.
Moreover, there was no evidence of significant aggregation in
water at the concentration used in this experiment (0.1 mM) for
HB254–270, although we have an indication of aggregation in
water for HB168–186 as shown in Figure 4C. In the isotherms
obtained, the total extent of incorporation (Xb
*) slowly increases
until a critical concentration is reached, where massive internal
aggregation apparently starts to develop.
The surface partition coefficients Kp were estimated by
extrapolating the initial slopes of the curves to Cf values of zero.
Curves are shown in Figure 5.
The Kp values for the peptides HB168–186 and HB254–270
are shown in Table 2. The Kp value obtained for HB168–186 is
2.5 10
4, indicating that the tryptophan in HB168–186 is able to
interact significantly with the bilayer and that most of the peptide
HB168–186 is located inside the liposomes. The Kp value for
HB254–270 is 3.2 10
4, indicating that the tyrosine residues present
in this peptide are located inside the liposomes and are stably
inserted.
Quenching of tryptophan/tyrosines by Acrylamide
The observed changes in the characteristics of the tryptophan/
tyrosine emission upon binding of peptides HB168–186 and
HB254–270 to lipid vesicles indicate their insertion into the
hydrophobic region of the bilayers. We also studied the
accessibility of the tryptophan/tyrosine residues of membrane-
bound peptides towards acrylamide, a neutral, water-soluble,
highly efficient quenching molecule, which is unable to penetrate
Figure 3. Ability of peptides to induce lipid mixing of inner-monolayer and membrane leakage. Peptide interactions with DOPC/Chol
LUVs (A–B), the dose dependence is reported and each trace represents an average of three independent experiments. A) Inner monolayer assay.
C) Leakage of ANTS/DPX.
doi:10.1371/journal.pone.0032186.g003
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tryptophan/tyrosine residue is buried, the less strongly it can be
quenched by acrylamide. Stern-Volmer plots for the quenching of
tryptophan by acrylamide, recorded in the absence and presence
of lipid vesicles, are depicted in Figure 6. Fluorescence of
tryptophan/tyrosine decreased in a concentration-dependent
manner by the addition of acrylamide to the peptide solution
both in the absence and presence of liposomes, without other
effects on the spectra. However, we can observe a substantial
difference between the two peptides. In the presence of liposomes,
a great decrease in fluorescence intensity was evident for HB254–
270, thus revealing that tyrosine residues are less accessible to the
quencher in the presence of LUVs. In fact, the values for Ksv were
lower (Table 3) in LUVs, suggesting that tyrosines were more
buried in the bilayers, becoming more inaccessible for quenching
by acrylamide. From Figure 6, it is evident that we can observe for
the peptide HB168–186 a low accessibility to the quencher both in
absence and presence of liposomes, indicating that the peptide has
a significant tendency to aggregate also in an aqueous solution.
ESR Results
The ESR spectroscopy, by using spin-labelled substances
(peptides and/or lipids) has been proved to give substantial
information on the interaction of peptide deriving from viral fusion
glycoproteins with lipid membranes [38–41]. In the present work,
the association of the two peptides, HB168–186 and HB254–270,
with lipid bilayers was investigated by analysing changes in ESR
spectra of spin-labelled phospholipids. The samples investigated
were phosphatidylcholine spin-labelled at different positions, n,i n
the sn-2 chain (n-PCSL, n=5, 7, 10, 14) incorporated in DOPC/
Chol membranes (3/2), in the presence of the peptides.
Preliminarily, the spectra in the absence of the peptides were
registered. Inspection of Figure 7A (solid lines) shows that all the
spectra present a clearly defined axially anisotropic lineshape, an
evidence that, due to the high cholesterol content, the DOPC/
Chol bilayer is in the liquid-ordered state [42]. In an attempt to
quantitatively analyse the spectra, the outer hyperfine splitting,
2Amax, was calculated. The 2Amax variation, shown in Figure 7B,
is an evidence of the flexibility gradient in segmental acyl chain
mobility [38,43], indicating that the lipid bilayer presents a rigid
surface and relatively fluid interior [44–47].
Association of peptides to the lipid bilayer causes a significant
variation in the ESR spectra of spin-labelled phospholipids. In
Figure 7A, ESR spectra of 5-PCSL and 14-PCSL in DOPC/Chol
bilayers, in the presence of HB168–186, HB254–270 and HB168–
186:HB254–270 mixture at a lipid/peptide weight ratio of 1/1,
are also reported. The presence of two peptides induces significant
changes in the spin-label ESR spectra, which are mainly
detectable from the low- and high-field component position and
lineshape. In an attempt to quantify this evidence, the 2Amax
values were determined. Figure 7B shows the dependence of these
parameters on chain position, n, for the n-PCSL spin-labels in
DOPC/Chol membranes, in the absence and in the presence of
the peptides. In all cases, the flexibility gradient with the chain
position of the lipid bilayer membranes is preserved. However,
inspection of the figure reveals a significantly different behaviour
of the lipid chain mobility in the co-presence of the two peptides.
In fact, addition of HB168–186 or HB254–270 significantly
reduces the 2Amax value of 5-PCSL. In both cases, no changes in
the spectra of the spin-labels bearing the nitroxide group in the
more interior positions were observed. Strikingly, addition of the
HB168–186:HB254–270 mixture results in a strongly 2Amax
decrease for all the considered spin-labels. These results show a
cooperation of the peptides in perturbing the bilayer microstruc-
ture in that only in the presence of both of them the increase of
segmental mobility propagates along the whole acyl chains. Thus,
the contemporary interaction of both peptides with the lipid
membrane surface effectively perturbs the local order and
dynamics of the lipid leaflet they come in contact with.
Secondary structure in lipid bilayers
The CD spectra of the peptides in buffer and bound to LUVs
made of DOPC/Chol are shown in Figure 8. The binding of the
peptides to the membrane bilayer did not affect their structure.
The spectra are indicative of random conformation for both
peptides.
Discussion
Membrane fusion is of fundamental importance in the
biological life of a cell and is of particular interest during
enveloped virus infections. A common feature of all fusion events is
the involvement of the fusion peptide in these phenomena and the
key role played by lipids in the conformational changes leading to
the interaction of the fusion peptide with target membranes, and
in the membrane deformation following the initial peptide-
membrane interactions. Extensive research data on viral mem-
brane fusion proteins have disclosed the existence of several
protein domains involved in the viral fusion process. It is, thus, an
accepted view the presence of different membrane-active regions
in viral fusion glycoproteins, although their biological function is
still unclear. It has been hypothesised that these regions may have
a different role on either pore formation and stabilization, viral
budding or both of them.
In the present work we have investigated the role played by the
two fusion loops of HSV-1 gB in the mechanism of membrane
fusion. In particular, three important issues were addressed: the
ability of peptide analogues of the fusion loops to induce fusion of
liposomes, their ability to interact with the membrane bilayer
when alone and when used in equimolar concentrations and the
role of the target membrane composition. For herpesviruses,
cholesterol is thought to play a key role, in fact, lipid raft may act
as a platform allowing cell entry and potential coreceptors
clustering [32] or cholesterol may modulate the HSV entry
process regardless of its ability to promote lipids microdomains
[48]. In this work evidences have been obtained indicating the
ability of the two fusion peptide to induce fusion of liposomes in
vitro, their ability to strongly interact with a membrane bilayer
containing cholesterol and finally their different mode of
interaction with the bilayer indicating that although being both
involved in the fusion mechanism they may play a different role.
The two fusion loops constitute a structural subdomain wherein
key hydrophobic amino acids form a ridge that is supported on
both sides by charged residues. The two charged residues located
on both sides of the ridge represent a novel feature of viral fusion
peptides and probably enhance the ability of the hydrophobic
residues to interact with target membranes and to promote fusion.
Figure 4. Peptide aggregation. Fluorescence variation of ThT after addition of HB168–186 (A) and HB254–270 (B) peptides to an aqueous solution
and in the presence of LUVs of DOPC/Chol at a peptide concentration of 4 mM. (C) Percentage of aggregation as a function of peptide concentration
for HB168–186 and HB254–270 in buffer (closed symbols) and in LUVs (open symbols).
doi:10.1371/journal.pone.0032186.g004
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* versus Cf for HB168–186 and HB254–
270.
doi:10.1371/journal.pone.0032186.g005
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dimensional structure of gB points out that the hydrophobic
residues do not appear to be able to insert deeply into a target
membrane. The hydrophilic residues on either side of the
hydrophobic ridge may help to stabilize insertion of gB into
cholesterol enriched membranes or more generally membranes
mimicking lipid rafts, but both fusion loops seem unable to deeply
penetrate into the hydrophobic core of the bilayer.
The fusion ability of the two peptides was analysed using LUVs
with different compositions. Membrane components, such as
anionic lipids (DOPG), unsaturated phospholipids (DOPC,
POPC), sphingolipid (SM) and cholesterol (Chol) were used in
this study. Lipid raft formation occurs by spontaneous aggregation
of certain naturally occurring lipids that aggregate in the plane of
the membrane and are characterized by a higher degree of
molecular order and by being thicker than the surrounding liquid-
disordered lipids in the membrane. To investigate lipid raft
characteristics in model membranes, Chol and SM are commonly
combined with phospholipids having unsaturated and therefore
kinked fatty acyl chains, such as POPC. Our results are consistent
with previous studies showing the specific association of gB with
cholesterol-rich rafts [32]. We found that gB peptides associate
with lower fusion ability with liposomes in the absence of
cholesterol. Our data further suggest that the cholesterol
dependence of gB is not necessarily dependent on a protein
receptor in rafts, but because cholesterol itself enhances insertion
of the fusion loops. In Semliki Forest virus fusion protein E1, a
class II fusion protein that inserts preferentially into membranes
enriched in cholesterol and sphingolipid [49], a point mutation in
the loop adjacent to the fusion loop confers increased cholesterol
independence [50,51].
Lipid mixing, inner-monolayer and leakage are three indepen-
dent experiments which describe different processes during the
interaction of peptides with liposomes. In particular, the lipid
mixing experiment evidences the fusion of both the inner and
outer monolayer, the inner monolayer experiment evidences the
eventual presence of fusion of the inner monolayer, while the
leakage describes the pore formation. Results were consistent
among the three experiments for both peptides, supporting the
hypothesis that the two peptides induce fusion of inner and outer
monolayers but not formation of pores whenever used alone or in
equimolar concentrations. The present results can be used as
qualitative indicators of bilayer perturbation due to its interaction
with the peptides and their superficially positioning. We have not
detected any significant pore formation; in fact, vesicle fusion
events were not accompanied by leakage of the aqueous contents
of the vesicle as also reported for other peptides in a study
published by Thoren et al. [52].
Table 2. Partition coefficient for the binding of peptides with
PC/Chol.
HB168–186 HB254–270
Kp (2.560.3)10
4 (3.260.2)10
4
doi:10.1371/journal.pone.0032186.t002
Table 3. Stern-Volmer (Ksv) quenching constant calculated
from the equation F0/F=1+Ksv [Q] for HB168–186 and
HB254–270.
HB168–186 HB254–270
Ksv (M
21) in buffer 8.360.2 71.161.1
Ksv (M
21) in LUVs 6.460.4 8.560.1
doi:10.1371/journal.pone.0032186.t003
Figure 6. Quenching of tryptophan/tyrosines by Acrylamide. Stern-Volmer plots of acrylamide quenching of HB168–186 and HB254–270 in
buffer (closed symbols) and in LUVs (open symbols).
doi:10.1371/journal.pone.0032186.g006
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demonstration of oligomerization concomitant to fusion taking
place. Although a correlation between penetration and fusion
awaits further experimental support, our results suggest that
oligomerization is another parameter related to the nature of the
interaction of the peptide with the target membrane and plays a
key role in governing fusion activity. The peptide HB168–186
presents a high tendency to oligomerize both in aqueous solution
and inside the membrane. On the contrary, the peptide HB254–
280 is not oligomerized in aqueous solution but it is able to
oligomerize when interacting with the membranes.
Tryptophan and tyrosine side chains are often found at the
interface between charged phospholipids and hydrophobic fatty
acid chains of lipid membranes. The Kp values for the two
peptides are reported in Table 2. Since Kp values are all of the
same order (10
4), we concluded that the peptides have similar
membrane-binding affinities. The values of Kp obtained are within
the range of those obtained for membrane-permeating bioactive
peptides such as mellitin and its derivatives [53], the Staphylo-
coccus d-toxin [54], the antibiotic dermaseptin [55], pardaxin
analogues [56]. All the results obtained support a shallow insertion
of the two peptides that may expand the head-group region of one
of the monolayers and generate elastic stresses that are released by
bilayer deformation. Our results demonstrate that these two gB
peptides bind and interact with membranes and could thus be
directly involved in merging of the viral and cellular membranes
and might work cooperatively with other membrane active regions
present on herpesvirus glycoproteins to boost the fusion process.
These results improve the current understanding of the critical
features required for viral fusogenic peptides to cross the
membrane bilayer and seem promising for the development of
new carrier peptides that could exploit viral membranotropic
peptides for intracellular delivery [57–59].
HSV-1 might have several domains involved in the fusion
process which either directly or indirectly, might interact with
biological membranes, contributing to the viral envelope and cell
membrane merging. Although the detailed mechanism of
herpesvirus entry remains unclear, some important insights into
the interplay of the proteins involved in membrane fusion have
been gained recently, but there are still many unsolved questions
such as if the two fusion loops are the only HSV fusion peptide;
what triggers them to be inserted into the target membrane, what
is the role of gH in fusion and if fusion domains present in gH are
directly involved in fusion.
Materials and Methods
Materials
The Phospholipids: 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-
choline (POPC), dioleoyl phosphatidylcholine (DOPC), dioleoyl
phosphatidylglycerol (DOPG), N-octadecanoyl-D-erythro-sphingo-
sylphosphorylcholine (SM), the fluorescent probes N-(7-nitro-
benz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine (NBD-PE)
and N-(Lissamine-rhodamine-B-sulfonyl) phosphatidylethanol-
amine (Rho-PE) were purchased from Avanti Polar Lipids
(Birmingham, AL, USA), while cholesterol (Chol) and Triton-
6100 were from Sigma (St. Louis, MO, USA). All other reagents
were of analytical grade. Spin-labelled phosphatidylcholines (n-
PCSL) with the nitroxide group at different positions, n, in the sn-2
acyl chain were synthesized as described by Marsh [60]. The spin-
labels were stored at 220uC in ethanol solutions at a concentra-
tion of 1 mg/mL.
Peptide synthesis
Peptides were synthesised using standard solid-phase-9-fluor-
enylmethoxycarbonyl (Fmoc) method as previously reported [25].
All purified peptides (purity higher than 98%) were obtained with
good yields (30–40%). Table 1 shows the sequences of all the
synthesized peptides. Peptide stock solutions were prepared in
buffer with 2% dimethyl sulfoxide (DMSO).
Liposome preparation
Large unilamellar vesicles (LUVs) consisting of DOPG, DOPG/
Chol (3/2), DOPC, DOPC/Chol (3/2), POPC/Chol (3/2),
Figure 7. ESR Results. (A) ESR spectra of 5-PCSL and 14-PCSL spin-
labels in DOPC/Chol membranes in the absence of peptides (solid line)
and in the presence of HB168–186 (dotted line), HB254–270 (dashed
line) and HB168–186–HB254–270 mixture (dashed-dotted line). (B)
Dependence on spin-label position, n, of the outer hyperfine splittings,
2Amax, of the n-PCSL in DOPC/Chol bilayers in the absence (#) and in
the presence of HB168–186 (&), HB254–270 (N) or HB168–186: HB254–
270 (m)a tT=2 5 uC.
doi:10.1371/journal.pone.0032186.g007
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Chol/SM (1/1/1), and when necessary containing Rho-PE and
NBD-PE, were prepared according to the extrusion method of
Hope et al. [61] in 5 mM HEPES, 100 mM NaCl, pH 7.4. Lipids
were dried from a chloroform solution with a nitrogen gas stream
and lyophilized overnight. For fluorescence and circular dichroism
experiments, dry lipid films were suspended in buffer by vortexing
for 1 h; then the lipid suspension was freeze-thawed 6 times and
extruded 20 times through polycarbonate membranes with 0.1 mm
diameter pores to produce LUVs. Lipid concentrations of
liposome suspensions were determined by phosphate analysis
[62]. For ESR spectroscopy, multi-lamellar vesicles (MLVs) were
prepared. In these samples, 1% (wt/wt) of the spin-label, dissolved
in ethanol, was added to the lipid mixture in organic solvent before
drying. MLVs suspensions were obtained by the same procedure
described above, excluding the extrusion step.
Lipid mixing assays
Membrane lipid mixing was monitored using the resonance
energy transfer assay (RET) reported by Struck et al. [63]. The
assay is based on the dilution of the NBD-PE (donor) and Rho-PE
(acceptor). Dilution due to membrane mixing results in an
increase in NBD-PE fluorescence. The change in donor emission
was monitored as aliquots of peptides were added to vesicles.
Vesicles containing 0.6 mol % of each probe were mixed with
unlabelled vesicles at a 1:4 ratio (final lipid concentration
0.1 mM). Small volumes of peptides in dimethylsulfoxide
(DMSO) were added; the final concentration of DMSO in the
peptide solution was no higher than 2%. The NBD emission at
530 nm was followed with the excitation wavelength set at
465 nm. A cut off filter at 515 nm was used between the sample
and the emission monochromator to avoid scattering interferenc-
es. The fluorescence scale was calibrated such that the zero level
corresponded to the initial residual fluorescence of the labelled
vesicles and the 100% value corresponding to complete mixing of
all lipids in the system was set by the fluorescence intensity of
vesicles upon the addition of Triton X-100 (0.05% v/v) at the
same total lipid concentrations of the fusion assay. Lipid mixing
experiments were repeated at least three times and results were
averaged. Control experiments were performed using a scrambled
peptide and DMSO. All the experiments were performed at
37uC.
Figure 8. Secondary structure in lipid bilayers. CD spectra of HB168–186 and HB254–270 in buffer and in DOPC/Chol LUVs.
doi:10.1371/journal.pone.0032186.g008
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measurement
Peptide-induced phospholipid-mixing of the inner monolayer
was measured by a modification of the phospholipid-mixing
measurement reported elsewhere [64]. The concentration of each
of the fluorescent probes within the liposome membrane was 0.6%
mol. LUVs were treated with sodium dithionite 100 mM (from a
stock solution of 1 M dithionite in 1 M TRIS, pH 10.0) to
completely reduce the NBD-labelled phospholipid located at the
outer monolayer of the membrane, for approximately 1 h on ice in
the dark. Sodium dithionite was then removed by size exclusion
chromatography through a Sephadex G-75 50 DNA Grade
filtration column (GE Healthcare) eluted with a buffer containing
10 mM TRIS, 100 mM NaCl, and 1 mM EDTA, pH 7.4.
Measurements of ANTS/DPX leakage
The ANTS/DPX assay [34] was used to measure the ability of
the peptide to induce leakage of ANTS/DPX pre-encapsulated in
liposomes. Details of this assay can be found elsewhere [35]. To
initiate a leakage experiment, the peptide, in a stock solution at
pH 7.4 containing 5 mM Hepes and 100 mM NaCl, was added to
the stirred vesicle suspension (0.1 mM lipid) at 37uC.
Thioflavin T assays for peptide aggregation
Peptide aggregation was assayed using Thioflavin T (ThT).
ThT associates rapidly with aggregated peptides giving rise to a
new excitation maximum at 450 nm and an enhanced emission at
482 nm [36]. LUVs in 100 mM NaCl, 10 mM Tris–HCl, 25 mM
ThT, pH 7.4 (final phospholipid concentration of 0.1 mM) were
titrated with a peptide concentration of 1, 4, 8, 12, 16, 20 mM.
Fluorescence was measured before and after the desired amount of
peptide was added into the cuvette using a Varian Cary Eclipse
fluorescence spectrometer at 37uC. Samples were excited at
450 nm (slit width, 5 nm) and fluorescence emission was recorded
at 482 nm (slit width, 5 nm). Aggregation was quantified
according to the equation, %A=(Ff2F0)/(Fmax2F0)6100, where
Ff is the value of fluorescence after peptide addition, F0 the initial
fluorescence in the absence of peptide and Fmax is the fluorescence
maximum obtained immediately after peptide addition. Kinetic
data were obtained at a concentration of 4 mM.
Tryptophan and Tyrosine fluorescence measurements
Emission spectra of the peptides (1 mM) containing the
tryptophan and tyrosine residue in the absence or presence of
target vesicles (DOPC/Chol 1/1) were recorded: between 300 and
400 nm with an excitation wavelength of 295 nm for the peptide
HB168–186 and 290 and 350 with an excitation wavelength of
274 nm for the peptide HB254–270.The degree of peptide
association with lipid vesicles was measured by adding lipid
vesicles to 1 mM peptides and the fluorescence intensity was
measured as a function of the lipid/peptide molar ratio, in three to
four separate experiments. The fluorescence values were corrected
by taking into account the dilution factor corresponding to the
addition of microliter amounts of liposomes and by subtracting the
corresponding blank. The lipid/peptide molar ratio was 200:1.
The binding of hydrophobic peptides to membranes can be
described as a partition equilibrium: Xb=K pCf where Kp is the
apparent partition coefficient in units of M
21,X b is the molar ratio
of bound peptide per total lipid and Cf is the equilibrium
concentration of the free peptide in solution, as previously
suggested by Schwarz et al. [65]. F‘ was obtained by extrapolation
of a double reciprocal plot of the total peptide fluorescence vs the
total lipid concentration in the outer leaflet, i.e. 1/F vs 1/0.6CL.
The fraction of membrane-bound peptide, fb, was determined by
the formula fb=(F2F0)/(F‘2F0), where F represents the fluores-
cence of peptide after the addition of the vesicles and F0 represents
the fluorescence of the unbound peptide. fb allowed us to calculate
the equilibrium concentration of free peptide in the solution, Cf,
and the extent of peptide binding Xb. Assuming that the peptides
were initially partitioned only over the outer leaflet of the SUV
(60% the total lipid) [66], values of Xb were corrected as follows:
Xb
*=X b/0.6.
The curve resulting from plotting Xb
* versus the concentration
of the free peptide, Cf, is the binding isotherm.
Tryptophan and Tyrosine quenching by Acrylamide
Aliquots of a 4 M solution of the water-soluble quencher were
added to the solution containing the peptide (1 mM) in the absence
or presence of liposomes at a peptide/lipid molar ratio of 1/200.
The maximal concentration of acrylamide is 0.2 mmol/ml.
Tryptophan fluorescence was measured with an excitation
wavelength of 295 nm, to reduce acrylamide absorbance (and
the resulting inner filter effect), and emission at a wavelength of
340 nm, to eliminate interference from the Raman band of water
[67] and tyrosine fluorescence was measured with an excitation
wavelength of 274 nm, and emission at a wavelength of 305. The
data were analyzed according to the Stern-Volmer equation [68],
F0/F=1+Ksv [Q], where F0 and F represent the fluorescence
intensities in the absence and the presence of the quencher (Q),
respectively, and Ksv is the Stern-Volmer quenching constant,
which is a measure of the accessibility of tryptophan to acrylamide.
Acrylamide does not significantly partition into the membrane
bilayer [67], and the value for Ksv is a reliable reflection of the
bimolecular rate constant for collisional quenching of the aromatic
residues present in the aqueous phase. Accordingly, Ksv is
determined by the amount of non-vesicle-associated free peptide
as well as the fraction of the peptide residing at the surface of the
bilayer.
Electron Spin Resonance Spectroscopy
ESR spectra were recorded with a 9 GHz Bruker Elexys E-500
spectrometer (Bruker, Rheinstetten, Germany). The lipid suspen-
sions to be investigated were transferred into 25 mL glass
capillaries and flame sealed. The capillaries were placed in a
standard 4 mm quartz sample tube containing light silicone oil for
thermal stability. All the measurements were performed at 25uC.
Spectra were recorded using the following instrumental settings:
sweep width, 100 G; resolution, 1024 points; time constant,
20.48 ms; modulation frequency, 100 kHz; modulation ampli-
tude, 1.0 G; incident power, 6.37 mW. Samples containing the
peptides were prepared by hydrating the lipid film directly with the
peptide solution in buffer. In all samples, the peptide to lipid ratio
was set to 1:1 wt/wt. In samples containing both HB168–186 and
HB254–270, the total peptide to lipid ratio was maintained to 1:1
wt/wt, while the HB168–186:HB254–270 ratio was 1:1 wt/wt.
Several scans, typically 16, were accumulated to improve the
signal-to-noise ratio. Values of the outer hyperfine splitting, 2Amax,
were determined by measuring the difference between the low-
field maximum and the high-field minimum, through a home-
made, MATLAB-based, software routine. This parameter is a
useful empirical measure of the lipid chain dynamics and order in
both gel and fluid phases of lipid bilayers [44–46]. The main
source of error on the 2Amax value is the uncertainty in composition
of samples prepared by mixing few microliters of mother solutions.
For this reason, reproducibility of 2Amax determinations was
estimated by evaluating its value for selected independently
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found to be 60.2–0.3 G.
Circular dichroism spectroscopy
CD spectra were recorded using a Jasco J-715 spectropolarim-
eter in a 1.0 cm quartz cell at room temperature. The spectra are
an average of 3 consecutive scans from 260 to 195 nm, recorded
with a band width of 3 nm, a time constant of 16 s, and a scan rate
of 10 nm/min. Spectra were recorded and corrected for the blank
sample. Mean residue ellipticities (MRE) were calculated using the
expression MRE=Obsd/(lcn), where Obsd is the ellipticity mea-
sured in millidegrees, l is the path length of the cell in cm, c is the
peptide concentration in mol/l, and n is the number of amino acid
residues in the peptide. Solutions of 4 mM of HB168–186 and
10 mM of HB254–270 with LUVs were prepared as described
previously [31]. The measurements were performed at peptide/
lipid ratios of 0.5 mol/mol.
Supporting Information
Figure S1 Fluorescence spectra of tryptophan and
tyrosine. Fluorescence spectra of HB168–186 and HB254–270
in buffer and in LUVs.
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